Literature DB >> 29581751

Tumor suppressor miR-211-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.

Jing Quan1,2,3, Xiang Pan1,2,3, Tao He1,3, Canbin Lin1,3, Yulin Lai1,3, Peijie Chen1,3, Zeng Zhang2,3, Shangqi Yang1, Tao Wang4, Yongqing Lai1,3.   

Abstract

Increasing evidence has demonstrated that microRNA (miRNA) serve an important role in the tumorigenesis of various types of cancer, such as renal cell carcinoma (RCC). The expression of miR-211-5p has been detected in RCC tissue by microarray profiling. However, studies regarding miR-211-5p and RCC remain rare. In the present study, the expression of miR-211-5p in RCC tissues and cell lines was revealed to be downregulated by reverse transcription-quantitative polymerase chain reaction analyses. The present results also revealed that the upregulation or downregulation of miR-211-5p inhibited or promoted, respectively, RCC cell proliferation, migration and invasion. In addition, the upregulation or downregulation of miR-211-5p induced or inhibited, respectively, RCC cell apoptosis. However, the present study only identified that downregulation of miR-211-5p promoted 786O and ACHN cell viability. The above results suggest that miR-211-5p may be a tumor suppressor in the tumorigenesis of RCC and may be a potential therapeutic target for RCC in the future. Further research should focus on the underlying mechanism of miR-211-5p in RCC and on investigating the possible use of miR-211-5p as a biomarker for RCC.

Entities:  

Keywords:  miR-211-5p; microRNA; renal cell carcinoma; tumor suppressor

Year:  2018        PMID: 29581751      PMCID: PMC5863605          DOI: 10.3892/etm.2018.5908

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  27 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification.

Authors:  Yong Sun; Chang Hyun Byon; Kaiyu Yuan; Jianfeng Chen; Xia Mao; Jack M Heath; Amjad Javed; Kui Zhang; Peter G Anderson; Yabing Chen
Journal:  Circ Res       Date:  2012-07-06       Impact factor: 17.367

Review 3.  Targeted Therapy for Metastatic Renal Cell Carcinoma.

Authors:  Andika Afriansyah; Agus Rizal Ah Hamid; Chaidir A Mochtar; Rainy Umbas
Journal:  Acta Med Indones       Date:  2016-10

4.  MicroRNA-134-3p is a novel potential inhibitor of human ovarian cancer stem cells by targeting RAB27A.

Authors:  Cui Chang; Te Liu; Yongyi Huang; Wenxing Qin; Hongtu Yang; Juan Chen
Journal:  Gene       Date:  2016-12-31       Impact factor: 3.688

5.  miR-130b-3p inhibits cell invasion and migration by targeting the Notch ligand Delta-like 1 in breast carcinoma.

Authors:  Yifang Shui; Xiaojing Yu; Rui Duan; Qianyi Bao; Jiahui Wu; Hongyan Yuan; Changyan Ma
Journal:  Gene       Date:  2017-02-03       Impact factor: 3.688

6.  MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.

Authors:  Ahmet Taner Sümbül; Bülent Göğebakan; Süleyman Bayram; Celal Yücel Batmacı; Serdar Öztuzcu
Journal:  Tumour Biol       Date:  2015-07-08

7.  MiR-211 inhibits cell proliferation and invasion of gastric cancer by down-regulating SOX4.

Authors:  Chen-Yu Wang; Long Hua; Juan Sun; Kun-Hou Yao; Jiang-Tao Chen; Jun-Jie Zhang; Jun-Hong Hu
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

8.  Wnt signaling regulates the lineage differentiation potential of mouse embryonic stem cells through Tcf3 down-regulation.

Authors:  Yaser Atlasi; Rubina Noori; Claudia Gaspar; Patrick Franken; Andrea Sacchetti; Haleh Rafati; Tokameh Mahmoudi; Charles Decraene; George A Calin; Bradley J Merrill; Riccardo Fodde
Journal:  PLoS Genet       Date:  2013-05-02       Impact factor: 5.917

9.  miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.

Authors:  Bairong Xia; Shanshan Yang; Tianbo Liu; Ge Lou
Journal:  Mol Cancer       Date:  2015-03-11       Impact factor: 27.401

10.  Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma.

Authors:  Akira Kurozumi; Mayuko Kato; Yusuke Goto; Ryosuke Matsushita; Rika Nishikawa; Atsushi Okato; Ichiro Fukumoto; Tomohiko Ichikawa; Naohiko Seki
Journal:  Int J Oncol       Date:  2016-03-15       Impact factor: 5.650

View more
  18 in total

1.  MiRNA-211 triggers an autophagy-dependent apoptosis in cervical cancer cells: regulation of Bcl-2.

Authors:  Shang Liu; Hongyan Wang; Jing Mu; Hao Wang; Yan Peng; Qi Li; Dongwei Mao; Liyuan Guo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-10-21       Impact factor: 3.000

2.  Deciphering the role of miR-187-3p/LRFN1 axis in modulating progression, aerobic glycolysis and immune microenvironment of clear cell renal cell carcinoma.

Authors:  Wenhao Xu; Wangrui Liu; Aihetaimujiang Anwaier; Xi Tian; Jiaqi Su; Guohai Shi; Shiyin Wei; Yuanyuan Qu; Hailiang Zhang; Dingwei Ye
Journal:  Discov Oncol       Date:  2022-07-07

3.  FBXO22 Suppresses Metastasis in Human Renal Cell Carcinoma via Inhibiting MMP-9-Mediated Migration and Invasion and VEGF-Mediated Angiogenesis.

Authors:  Feng Guo; Jinjin Liu; Xiao Han; Xuping Zhang; Tian Lin; You Wang; Jin Bai; Junqing Han
Journal:  Int J Biol Sci       Date:  2019-01-24       Impact factor: 6.580

4.  HOTAIR regulates colorectal cancer stem cell properties and promotes tumorigenicity by sponging miR-211-5p and modulating FLT-1.

Authors:  Ye Huang; Liang Wang; Di Liu
Journal:  Cell Cycle       Date:  2021-09-01       Impact factor: 5.173

5.  MicroRNA-204-5p: A novel candidate urinary biomarker of Xp11.2 translocation renal cell carcinoma.

Authors:  Ryoma Kurahashi; Tsuyoshi Kadomatsu; Masaya Baba; Chiaki Hara; Hitoshi Itoh; Keishi Miyata; Motoyoshi Endo; Jun Morinaga; Kazutoyo Terada; Kimi Araki; Masatoshi Eto; Laura S Schmidt; Tomomi Kamba; W Marston Linehan; Yuichi Oike
Journal:  Cancer Sci       Date:  2019-05-24       Impact factor: 6.716

6.  Selective downregulation of distinct circRNAs in the tissues and plasma of patients with primary hepatic carcinoma.

Authors:  Yan Ding; Anning Fang; Jialai Yan; Jie Duan; Nianyue Wang; Yongxiang Yi; Chuanlai Shen
Journal:  Oncol Lett       Date:  2019-09-23       Impact factor: 2.967

7.  Analysis of lncRNA-miRNA-mRNA expression pattern in heart tissue after total body radiation in a mouse model.

Authors:  Molykutty J Aryankalayil; Shannon Martello; Michelle A Bylicky; Sunita Chopra; Jared M May; Aman Shankardass; Laurel MacMillan; Landy Sun; Jaleal Sanjak; Claire Vanpouille-Box; Iris Eke; C Norman Coleman
Journal:  J Transl Med       Date:  2021-08-07       Impact factor: 5.531

8.  miR-19b serves as a prognostic biomarker of breast cancer and promotes tumor progression through PI3K/AKT signaling pathway.

Authors:  Chuansheng Li; Jingwei Zhang; Zhongliang Ma; Fan Zhang; Wenlong Yu
Journal:  Onco Targets Ther       Date:  2018-07-16       Impact factor: 4.147

9.  Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.

Authors:  Yibin Deng; Zhongheng Wei; Meijin Huang; Guidan Xu; Wujun Wei; Bin Peng; Shunqiang Nong; Houji Qin
Journal:  J Cell Mol Med       Date:  2019-12-27       Impact factor: 5.310

10.  Long non‑coding RNA TTN‑AS1 regulates the proliferation, invasion and migration of triple‑negative breast cancer by targeting miR‑211‑5p.

Authors:  Erhu Sun; Xiaofeng Liu; Cheng Lu; Kangsheng Liu
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.